Fujifilm to spend $5bn to become global contract drugmaker

Nikkei Asia | Nov. 21, 2021, 1 a.m. | Original

TOKYO -- Fujifilm Holdings is staking its future on becoming a provider of drug development and manufacturing services to other pharmaceutical companies.

Academy Award-winning Japanese costume designer Wada dies at 84 Vietnam PM visits Japan, Asia-Europe summit, Marcos Jr. in focus